This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.
Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases. DOWNLOAD OUR DIGITAL MAGAZINE HERE. The post Unpacking rare diseases in the first edition of Delta magazine appeared first on.
The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. The pharma company’s senior vice president for major markets talks about the continued evolution of the industry’s approach to communications and commercialisation.
wants to ensure the ensuing the US does not lag behind other countries in drugdevelopment. We want to make sure we are getting rid of the regulatory impediments [that stop drugs getting to market],” RFK Jr stated. We may still continue to send you service-related and other non-promotional communications.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drugdevelopment. Can pharma tariffs “Make America Manufacture Again”?
We may still continue to send you service-related and other non-promotional communications. Can pharma tariffs “Make America Manufacture Again”? By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy.
Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drugdevelopment in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Can pharma tariffs “Make America Manufacture Again”?
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
“SIM0505 is a significantly differentiated CDH6 targeting ADC candidate independently developed by Simcere Zaiming. Our alliance reflects NextCure’s recognition of our proprietary ADC platform, and together, we aim to accelerate drugdevelopment to benefit more cancer patients worldwide.”
Outsourcing is now a fundamental part of drugdevelopment and distribution. Outsourcing is now a fundamental part of drugdevelopment and distribution. Can pharma tariffs “Make America Manufacture Again”? Sign up for our daily news round-up!
Pharma companies are embracing patient centricity in drugdevelopment more than ever before. Over the last decade, leaders in the industry have championed patient engagement, putting it at the heart of commercial strategies. I don’t want to be called a patient, and I’m not on a journey.”.
Medical writing refers to creating healthcare-related textual content that aims to improve doctor-patient communication and provide insights on industry topics. Medical writers must be outstanding communicators, capable of breaking down complex ideas for the public and healthcare professionals in a digestible way.
Can pharma tariffs “Make America Manufacture Again”? Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. The parallel shift to using real-world data (RWD) provides the ideal framework for further investigation into SDoH. Sign up for our daily news round-up!
In recent years, the pharmaceutical industry has exhibited a significant shift into digitalisation, with AI pushing for innovation across the entire drugdevelopment value chain, from accelerating drug discovery to optimising clinical trial design to ultimately improve patient outcomes.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
We may still continue to send you service-related and other non-promotional communications. Can pharma tariffs “Make America Manufacture Again”? By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?
TEV-56278 demonstrates the strength of Teva’s innovative drugdevelopment capabilities and how strategic partnerships with companies such as Fosun Pharma play a pivotal role in advancing therapies on behalf of patients.” Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
He said the cuts concerned redundancies caused by certain departments having their own legislative, communication staff, and in other departments like HR and procurement – which constitute about 10% of the entire agency staff. Reports Use of Artificial Intelligence in Pharmaceutical DrugDevelopment a.
We may still continue to send you service-related and other non-promotional communications. Can pharma tariffs “Make America Manufacture Again”? By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy.
Drugdevelopment alone is not really working to solve [chronic illness],” he added, noting that BIOS aims to use AI to read these neural signals, find out how they work and eventually control them to produce a therapeutic effect. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. About the author.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content